Taking stock: Musings from Munich

Share on facebook
Share on twitter
Share on linkedin

“Nur die Harten kommen in den Garten.”

Old German proverb

The RWC European Equities team attended the Baader Investment Conference last week in Munich. This year’s event took place in a hybrid format, providing the team with an opportunity for a virtual catch up with the management teams of more than thirty German businesses.

Unsurprisingly, there was a significant divergence in tone from different companies. At one extreme, businesses that are benefiting from the amount of time people are spending at home and socially distancing, tended to present an upbeat assessment of their current operations. At the other end of the spectrum were some of the companies which operate in industries that have been existentially threatened by the pandemic.

Within the former group, the team held a series of meetings with online retailers, which naturally saw a meaningful pickup in demand during the first couple of months of lockdown. Many analysts had initially assumed that this accelerated demand would prove to be a temporary phenomenon, but it is becoming increasingly clear that there is an element of longevity to the change in consumer behaviour. For some businesses, these newly acquired customers are proving stickier than expected and many are spending more than longer-standing customers. Rather than bringing a temporary boost to trade, therefore, it now feels like the pandemic has permanently changed the extent of online retail penetration in Europe, delivering several years of growth in a matter of months.

On the other hand, the narrative from practically any business exposed to the travel industry, has clearly been hit extremely hard by the pandemic and very few businesses are seeing meaningful signs of demand returning. This absence of demand is clearly a concern, particularly for businesses which have a significant debt burden or a high degree of fixed costs. To paraphrase the old German proverb above, perhaps only the strongest will survive.

Of course, equity markets have already responded to the dichotomy in operational performance – the Covid winners have traded well, with many share prices moving to new all-time highs over the summer, whereas the share prices of many of the Covid losers continue to languish near the lows that prevailed in March. Care is therefore required when sifting through the opportunity set to ascertain which of the market’s recent winners can sustain their superior performance and which of the perceived losers ultimately have robust recovery prospects.

The healthcare industry has seen its fair share of winners this year, and the team has a number of medical technology positions that have benefited from a step-change in demand as a result of the health crisis. The resounding theme from the team’s conversations with healthcare companies was that a near-term breakthrough in the race for a vaccine is unlikely. The consensus among healthcare professionals is that a vaccine may become available in the spring of next year. But the availability of a vaccine won’t immediately reduce the need for Covid testing, because it will take a long time to roll it out universally. The demand outlook for Europe’s testing and diagnostics businesses, therefore, looks robust for some time to come.

Last week’s highlights

With Europe seemingly on the brink of the introduction of further measures in the fight against the coronavirus, equity markets appear to have returned to some of the themes that performed well during the original lockdown of spring. Our portfolios are positively skewed towards this market dynamic with holdings such as HelloFresh, ASOS, Avast, Teleperformance, Ambu and Domino’s Pizza, all seen as beneficiaries of the current environment.

The team met with Europe’s largest optician, Fielmann, during the Munich conference, for an update on recent trading. This is a portfolio holding with many attractive characteristics, and the company’s response to the pandemic has brought about an unexpected productivity benefit. Historically, one of the constraints to growth has been finding enough medically trained staff to handle its flow of customers, with eye tests and spectacles purchases often treated as separate store visits. However, post lockdown, the company has introduced a new booking system, which in the vast majority of cases, has led to spectacles being purchased at the same time as the eye test.

Within the RWC UK Focus Fund, Pearson performed well last week, with US undergraduate enrolment data falling by less than the company had expected this autumn. The company looks poised to benefit from the counter-cyclical nature of higher and professional education, as well as increasing interest in its online education services. The team made good returns from this stock as it emerged from the global financial crisis. From here, with a new chief executive in place, it offers both cyclical and recovery potential.  

The statements and opinions expressed in this article are those of the author as of the date of publication, and do not necessarily represent the view of RWC Partners Limited. Past performance is not a guide to the future. The price of investments and the income from them may fall as well as rise and investors may not get back the full amount invested. This article does not constitute investment advice and the names shown above is for illustrative purposes only and should not be construed as a recommendation or advice to buy or sell any security. No investment strategy or risk management technique can guarantee returns or eliminate risks in any market environment

The term “RWC” may include any one or more RWC branded entities including RWC Partners Limited and RWC Asset Management LLP, each of which is authorised and regulated by the UK Financial Conduct Authority and, in the case of RWC Asset Management LLP, the US Securities and Exchange Commission; RWC Asset Advisors (US) LLC, which is registered with the US Securities and Exchange Commission; and RWC Singapore (Pte) Limited, which is licensed as a Licensed Fund Management Company by the Monetary Authority of Singapore.

RWC may act as investment manager or adviser, or otherwise provide services, to more than one product pursuing a similar investment strategy or focus to the product detailed in this document. RWC seeks to minimise any conflicts of interest, and endeavours to act at all times in accordance with its legal and regulatory obligations as well as its own policies and codes of conduct.

This document is directed only at professional, institutional, wholesale or qualified investors. The services provided by RWC are available only to such persons. It is not intended for distribution to and should not be relied on by any person who would qualify as a retail or individual investor in any jurisdiction or for distribution to, or use by, any person or entity in any jurisdiction where such distribution or use would be contrary to local law or regulation.

This document has been prepared for general information purposes only and has not been delivered for registration in any jurisdiction nor has its content been reviewed or approved by any regulatory authority in any jurisdiction. The information contained herein does not constitute: (i) a binding legal agreement; (ii) legal, regulatory, tax, accounting or other advice; (iii) an offer, recommendation or solicitation to buy or sell shares in any fund, security, commodity, financial instrument or derivative linked to, or otherwise included in a portfolio managed or advised by RWC; or (iv) an offer to enter into any other transaction whatsoever (each a “Transaction”). No representations and/or warranties are made that the information contained herein is either up to date and/or accurate and is not intended to be used or relied upon by any counterparty, investor or any other third party.

RWC uses information from third party vendors, such as statistical and other data, that it believes to be reliable. However, the accuracy of this data, which may be used to calculate results or otherwise compile data that finds its way over time into RWC research data stored on its systems, is not guaranteed. If such information is not accurate, some of the conclusions reached or statements made may be adversely affected. RWC bears no responsibility for your investment research and/or investment decisions and you should consult your own lawyer, accountant, tax adviser or other professional adviser before entering into any Transaction. Any opinion expressed herein, which may be subjective in nature, may not be shared by all directors, officers, employees, or representatives of RWC and may be subject to change without notice. RWC is not liable for any decisions made or actions or inactions taken by you or others based on the contents of this document and neither RWC nor any of its directors, officers, employees, or representatives (including affiliates) accepts any liability whatsoever for any errors and/or omissions or for any direct, indirect, special, incidental, or consequential loss, damages, or expenses of any kind howsoever arising from the use of, or reliance on, any information contained herein.

Information contained in this document should not be viewed as indicative of future results. Past performance of any Transaction is not indicative of future results. The value of investments can go down as well as up. Certain assumptions and forward looking statements may have been made either for modelling purposes, to simplify the presentation and/or calculation of any projections or estimates contained herein and RWC does not represent that that any such assumptions or statements will reflect actual future events or that all assumptions have been considered or stated. Forward-looking statements are inherently uncertain, and changing factors such as those affecting the markets generally, or those affecting particular industries or issuers, may cause results to differ from those discussed. Accordingly, there can be no assurance that estimated returns or projections will be realised or that actual returns or performance results will not materially differ from those estimated herein. Some of the information contained in this document may be aggregated data of Transactions executed by RWC that has been compiled so as not to identify the underlying Transactions of any particular customer.

The information transmitted is intended only for the person or entity to which it has been given and may contain confidential and/or privileged material. In accepting receipt of the information transmitted you agree that you and/or your affiliates, partners, directors, officers and employees, as applicable, will keep all information strictly confidential. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon, this information is prohibited. The information contained herein is confidential and is intended for the exclusive use of the intended recipient(s) to which this document has been provided. Any distribution or reproduction of this document is not authorised and is prohibited without the express written consent of RWC or any of its affiliates.

Changes in rates of exchange may cause the value of such investments to fluctuate. An investor may not be able to get back the amount invested and the loss on realisation may be very high and could result in a substantial or complete loss of the investment. In addition, an investor who realises their investment in a RWC-managed fund after a short period may not realise the amount originally invested as a result of charges made on the issue and/or redemption of such investment. The value of such interests for the purposes of purchases may differ from their value for the purpose of redemptions. No representations or warranties of any kind are intended or should be inferred with respect to the economic return from, or the tax consequences of, an investment in a RWC-managed fund. Current tax levels and reliefs may change. Depending on individual circumstances, this may affect investment returns. Nothing in this document constitutes advice on the merits of buying or selling a particular investment. This document expresses no views as to the suitability or appropriateness of the fund or any other investments described herein to the individual circumstances of any recipient.

AIFMD and Distribution in the European Economic Area (“EEA”)

The Alternative Fund Managers Directive (Directive 2011/61/EU) (“AIFMD”) is a regulatory regime which came into full effect in the EEA on 22 July 2014. RWC Asset Management LLP is an Alternative Investment Fund Manager (an “AIFM”) to certain funds managed by it (each an “AIF”). The AIFM is required to make available to investors certain prescribed information prior to their investment in an AIF. The majority of the prescribed information is contained in the latest Offering Document of the AIF. The remainder of the prescribed information is contained in the relevant AIF’s annual report and accounts. All of the information is provided in accordance with the AIFMD.

In relation to each member state of the EEA (each a “Member State”), this document may only be distributed and shares in a RWC fund (“Shares”) may only be offered and placed to the extent that (a) the relevant RWC fund is permitted to be marketed to professional investors in accordance with the AIFMD (as implemented into the local law/regulation of the relevant Member State); or (b) this document may otherwise be lawfully distributed and the Shares may lawfully offered or placed in that Member State (including at the initiative of the investor).

Information Required for Distribution of Foreign Collective Investment Schemes to Qualified Investors in Switzerland

The representative and paying agent of the RWC-managed funds in Switzerland (the “Representative in Switzerland”) is Société Générale, Paris, Zurich Branch, Talacker 50,

P.O. Box 5070, CH-8021 Zurich. In respect of the units of the RWC-managed funds distributed in Switzerland, the place of performance and jurisdiction is at the registered office of the Representative in Switzerland.

Explore more

Taking stock: Tech-tonic shifts

Dealing with a large and diverse investment universe, such as the one that Europe’s collective equity markets represents…

Taking stock: You’re due an upgrade

We have seen a number of positive profit warnings across the portfolio in recent weeks, which in aggregate, have had a beneficial impact on performance…

Taking stock: Catching falling knives

There is a regularly used phrase in financial markets, which becomes particularly popular in times of market stress: “Don’t catch falling knives”…

Taking stock: Where to from here?

European stock markets appear to lack direction at the moment. Following the steep sell-off in Q1 as the coronavirus crisis gripped global financial markets…


Please confirm your investor type



By clicking Submit, you agree that you have read and accepted the terms and conditions detailed in the DISCLAIMER

This website uses cookies. A cookie is a small data file placed on your computer which captures information about your choices which allows us to improve your experience of the website, for example, by remembering your country of residence. By continuing to access this website, you agree to be bound by our Cookie Policy. You can accept and/or block at any time by changing your browser settings.


Where are you located?



Rest of world

By clicking Submit, you agree that you have read and accepted the terms and conditions detailed in the DISCLAIMER


What type of investor are you?



By clicking Submit, you agree that you have read and accepted the terms and conditions detailed in the DISCLAIMER